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The yeast [PSI] prion is an epigenetic modifier of translation termination fidelity that causes nonsense suppression. The
prion [PSI] forms when the translation termination factor Sup35p adopts a self-propagating conformation. The presence
of the [PSI] prion modulates survivability in a variety of growth conditions. Nonsense suppression is essential for many
[PSI]-mediated phenotypes, but many do not appear to be due to read-through of a single stop codon, but instead are
multigenic traits. We hypothesized that other global mechanisms act in concert with [PSI] to influence [PSI]-mediated
phenotypes. We have identified one such global regulator, the Paf1 complex (Paf1C). Paf1C is conserved in eukaryotes and
has been implicated in several aspects of transcriptional and posttranscriptional regulation. Mutations in Ctr9p and other
Paf1C components reduced [PSI]-mediated nonsense suppression. The CTR9 deletion also alters nonsense suppression
afforded by other genetic mutations but not always to the same extent as the effects on [PSI]-mediated read-through. Our
data suggest that the Paf1 complex influences mRNA translatability but not solely through changes in transcript stability
or abundance. Finally, we demonstrate that the CTR9 deletion alters several [PSI]-dependent phenotypes. This provides
one example of how [PSI] and genetic modifiers can interact to uncover and regulate phenotypic variability.
INTRODUCTION
Termination of translation is signaled when a stop codon in
the mRNA reaches the A site of the ribosome. In eukaryotes,
the conserved proteins eRF1 and eRF3 recognize the stop
codon and catalyze polypeptide release from the ribosome
to terminate translation (Frolova et al., 1994; Stansfield et al.,
1995b; Zhouravleva et al., 1995). Termination is a highly
accurate process, and several factors that contribute to this
fidelity have been identified (reviewed in von der Haar and
Tuite, 2007). However, the molecular mechanism of how
many of these factors contribute to faithful translation ter-
mination has not been fully elucidated. Mutant screens in
Saccharomyces cerevisiae have identified genetic factors such
as suppressor tRNAs, 18S rRNA, and ribosomal proteins
that contribute to the accuracy of translation termination
(reviewed in Beier and Grimm, 2001; Bertram et al., 2001;
Valente and Kinzy, 2003). Factors that regulate polyA tail
length and mRNA stability, such as Upf1p, Upf2p, Upf3p,
Dcp1p, Pab1p, Pop2p, and Tpa1p, also influence faithful
termination (Weng et al., 1996; Czaplinski et al., 1998; Cosson
et al., 2002; Keeling et al., 2006; Kofuji et al., 2006). Overex-
pression of Mtt1p/Ecm32p, Itt1p, Sso1p, Stu2p, eEF1B,
snR18, and Ssb1p, specific mutations in actin, up-regulation
of tRNAs, and loss of SAL6/PPQ1 or DBP5 have all been
shown to modify the efficiency of translation termination
(Song and Liebman, 1987; Czaplinski et al., 2000; Urakov et
al., 2001; Kandl et al., 2002; Kwapisz et al., 2002; Namy et al.,
2002; Gross et al., 2007; Hatin et al., 2007); however, the
mechanisms by which many of these factors affect termina-
tion have not been elucidated. Epigenetic factors that influ-
ence translation termination such as [PSI] and [ISP] have
also been identified (Cox, 1965; Volkov et al., 2002).
In S. cerevisiae and other yeasts, eRF3 is encoded by SUP35
(Stansfield et al., 1995b). Interestingly, eRF3/Sup35p exists in
two different states in yeast (Patino et al., 1996; Paushkin et
al., 1996). In the soluble state, Sup35p functions with eRF1/
Sup45p to terminate translation (Stansfield et al., 1995b).
However, Sup35p can fold into an alternative conformation
that is self-propagating, referred to as the prion [PSI]
(Patino et al., 1996; Paushkin et al., 1996). In the [PSI] state,
Sup35p is aggregated and the protein aggregates are herita-
ble through mitosis and meiosis. [PSI] cells exhibit in-
creased nonsense suppression (or read-through of stop
codons), presumably because aggregated Sup35p cannot
participate effectively in translation termination. Multiple
strain variants of the [PSI] prion, differing in their level of
nonsense suppression, can exist within different cells of the
same genetic background (Derkatch et al., 1996). The level of
nonsense suppression exhibited by strains of [PSI] in-
versely correlates with the amount of soluble Sup35p (Zhou
et al., 1999; Kochneva-Pervukhova et al., 2001; Uptain et al.,
2001). Strong [PSI] strain variants have high nonsense
suppression, show little soluble Sup35p, and generally have
high mitotic and meiotic stability (Derkatch et al., 1996; Zhou
et al., 1999; Kochneva-Pervukhova et al., 2001; Uptain et al.,
2001). In contrast, [PSI] strain variants with lower non-
sense suppression have more soluble Sup35p as well as
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lower mitotic and meiotic stability and are called weak
[PSI]. [PSI] strain variants rarely interconvert and pri-
marily arise by spontaneous or induced conversion from
[psi]. Prion strain variants are not due to genetic differ-
ences; rather they are due to different self-replicating Sup35p
conformations (Derkatch et al., 1996; Krishnan and Lindquist,
2005; Tanaka et al., 2005; Toyama et al., 2007).
The domains of Sup35p that function in prion propagation
and translation termination are separable (Ter-Avanesyan et
al., 1993, 1994). The N-terminal region alone is capable of
forming transmissible prion aggregates (Ter-Avanesyan et
al., 1994; Li and Lindquist, 2000). Mutations in, or deletion
of, the Sup35p N-terminal domain result in an inability to
propagate [PSI] but allow faithful translation termination
(Doel et al., 1994; Ter-Avanesyan et al., 1994; DePace et al.,
1998). Mutations in the essential C-terminal domain that
reduce function result in less efficient translation termination
and cause nonsense suppression (Ter-Avanesyan et al., 1993;
Bradley et al., 2003). However, there is cross-talk between the
domains. The N-terminal domain influences nonsense sup-
pression in Sup35 C-terminal domain mutants (Volkov et al.,
2007). Nonetheless, the N-terminal region is both necessary
and sufficient for [PSI] prion propagation, and the C-
terminal domain alone is necessary and sufficient for trans-
lation termination.
Interestingly, we and others have previously shown that
completely isogenic [PSI] and [psi] yeast strains differ in
many different growth phenotypes, including changes in
colony morphology (Eaglestone et al., 1999; True and
Lindquist, 2000; Namy et al., 2008). Furthermore, the specific
phenotypic effects were dependent on the genetic back-
ground of the strains used. [PSI] permitted better growth
in some conditions tested, whereas [psi] enhanced growth
in other conditions. In further studies, we demonstrated that
many of the phenotypic changes could be attributed to
[PSI]-mediated nonsense suppression and not other prop-
erties of [PSI], such as protein aggregation (True et al.,
2004). Nonsense suppression can occur at stop codons at the
3 ends of normal mRNAs or at premature stop codons. As
a result, [PSI]-mediated nonsense suppression has the po-
tential to produce polypeptides with C-terminal extensions,
to merge contiguous open reading frames into a single
polypeptide, and to facilitate the translation of pseudogenes
and other disabled open reading frames (Harrison et al.,
2002; Namy et al., 2002, 2003, 2008; Giacomelli et al., 2007).
The hidden variation revealed by [PSI] in these normally
untranslated regions has lead to the proposal that [PSI]
may generate adaptive phenotypic variants and increase the
rate of evolvability (True and Lindquist, 2000; Masel and
Bergman, 2003; Masel, 2006). In addition, [PSI]-mediated
read-through affects mRNA stability both by stabilizing mR-
NAs normally subjected to nonsense mediated decay and by
triggering nonstop decay (Wilson et al., 2005). These may be
additional sources of [PSI]-mediated genetic variation
(True et al., 2004; Wilson et al., 2005). Interestingly, although
read-through was essential for the phenotypic effects, many
did not appear to be due to nonsense suppression of a single
transcript but instead were complex, polygenic traits. This
suggests that many modifiers, and perhaps many other cel-
lular pathways, can contribute to the effects of [PSI] on
phenotypic diversity. Furthermore, because many of the
phenotypes are multigenic, modifiers may exist that broadly
affect the level of read-through and have the potential to
influence many phenotypes. In this study, we identify a
genetic modifier of [PSI]-mediated traits and show that
[PSI] and genetic modifiers can interact to regulate pheno-
typic variability.
MATERIALS AND METHODS
Yeast Strains and Plasmids
Yeast cells were cultured and manipulated using standard techniques. Yeast
strains were grown in rich media (YPD: 1% yeast extract, 2% peptone, 2%
dextrose) or synthetic dropout media (SD) lacking one or more components as
needed to select for plasmids or assay for nonsense suppression. Solid media
contained 2% agar. Additions of G418, guanidine hydrochloride (GdnHCl),
hygromycin B, neomycin sulfate, and cycloheximide were at the final con-
centrations noted in the figure legends. Colony morphology was assayed on
KOAc media (1% yeast extract, 2% peptone, 3% potassium acetate, 2% agar).
Suppression of the lys1-1 allele in 10B-H49 was assayed on SD medium
lacking lysine with 3% glycerol, as the use of glycerol as the carbon source
enhances nonsense suppression in 10B-H49. Diploids were sporulated on
0.98% potassium acetate, 0.05% glucose, 0.1% yeast extract, 1.5% agar, 0.08%
CSM powder (BIO-101, Carlsbad, CA) for 10 d before micromanipulation
of asci.
All yeast strains used in this study except for those used in Figure 9 were
derived from 74-D694 (MATa ade1-14 trp1-289 his3-200 ura3-52 leu2-3112).
74-D694 containing strong [PSI] was a gift of Y. Chernoff (Georgia Institute
of Technology, Atlanta, GA) (Chernoff et al., 1995), as was the 74-D694 strain
OT69 containing the sup45 mutation. The weak [PSI] (Derkatch et al., 1996)
and [psi] sup35-Y351C (Bradley et al., 2003) strains were provided by S.
Liebman (University of Illinois at Chicago, Chicago, IL). The [psi] strain was
generated in our laboratory by multiple passages of the strong [PSI] strain
on YPD supplemented with 3 mM GdnHCl. Strains used in Figure 9 were
derivatives of 5V-H19 (MATa ade2-1 can1-100 leu2-3112 ura3-52 SUQ5; Ter-
Avanesyan et al., 1993) or 10B-H49 (MAT ade2-1 SUQ5 lys1-1 his3-11,15 leu1
kar1-1; Ter-Avanesyan et al., 1994) and were obtained from M. Ter-Avanesyan
(Institute of Experimental Cardiology, Moscow, Russia). In these strains the
nonsense suppression depends on both [PSI] and SUQ5. The coding regions
of CTR9, PAF1, CDC73, LEO1, and RTF1 were replaced with HIS3MX6 or
loxP-LEUMX-loxP using the method of Baudin et al. (1993) and pFA6a-
HIS3MX6 (Wach et al., 1997) or pUG73 (Gueldener et al., 2002) as template. All
knockouts were confirmed by colony PCR.
Plasmids were constructed using standard molecular biology techniques
and maintained in DH5. The shuttle vectors pRS315 (LEU2 CEN6 ARSH4)
and pRS316 (URA3 CEN6 ARSH4) were described previously (Sikorski and
Hieter, 1989). pRS316kanMX4 contains kanMX4 in the f1 origin of pRS316 and
can be selected in yeast via URA3 or kanMX4. This plasmid was constructed
by removing kanMX4 from pFA6a-kanMX4 (Wach et al., 1994) with BglII and
SacI, making the fragment blunt with Klenow, and ligating it into the
NgoMIV site (made blunt with Klenow) of pRS316 (Sikorski and Hieter, 1989).
Wild-type CTR9 from 74-D694a and mutant ctr9 from SV16 were cloned into
pRS316kanMX4 by PCR amplifying the gene from each strain with oligos
(5-CTACGGCCGCTTTTTTGAATTACACTATCCATC-3 and 5-CTACTC-
GAGAGGACACGAAAAGGTGGATG-3), digesting the resulting PCR
products with EagI and XhoI and ligating them into the same sites of
pRS316kanMX4.
Screen for Factors that Reduce Nonsense Suppression
Strain 74-D694a containing strong [PSI] was mutagenized with ethylmeth-
ane sulfonate as previously described (Lawrence, 1991) to 17% viability. Cells
were plated onto YPD plates at 500–700 colonies per plate and incubated at
30°C for 6–7 d before visually screening for colonies that were darker pink
than the original, unmutagenized light pink parental strain. Approximately
133,000 colonies were screened. Solid, darker pink colonies were restruck to
YPD at least two additional times to assess the maintenance of the phenotype.
Thirty-two mutants that consistently and uniformly produced solid, darker
pink colonies were kept for further analysis.
Cloning SV16 by Complementation
The gene that is responsible for the reduced nonsense suppression in mutant
SV16 was cloned by complementation of the poor growth phenotypes on
SD-ade and YPD containing 3 mM GdnHCl. SV16 was independently trans-
formed with two different libraries. S. cerevisiae genomic libraries in either
p366 (LEU2 CEN; American Type Culture Collection, Manassas, VA; number
77162, deposited by Philip Hieter) or pRS316kanMX4 (URA3 kanMX4 CEN)
made in our laboratory (unpublished data) were used. Approximately 108,000
and 17,400 transformants from the LEU2 CEN and URA3 kanMX4 CEN
libraries, respectively, were screened. Library plasmids that complemented
both poor growth phenotypes were rescued from transformants and retested.
On retesting, eight isolates were identified that complemented both pheno-
types. To evaluate specificity, each of the plasmids was tested in strong
[PSI], weak [PSI], and [psi] strains for an effect on nonsense suppression
by color or growth on SD-ade. Six of the plasmids passed this secondary test.
Both ends of the inserts in the complementing plasmids were sequenced
(Protein Nucleic Acid Chemistry Laboratory, Washington University School
of Medicine). All six library plasmids contained overlapping regions of the
same genomic region. CTR9 was the only gene common to all six plasmids.
To compare the sequences of CTR9 from SV16 and wild-type, the sequence
of the CTR9 locus from SV16 or 74-D694a was gap-repaired into plasmid A186
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(isolated from the LEU2 CEN genomic library) digested with SwaI and MluI
to remove most of the CTR9 coding region. CTR9 in the two gap-repaired
plasmids was sequenced using ABI Big Dye v3.1 chemistry and the sequences
from wild-type 74-D694 and SV16 were compared.
Growth Assays
[PSI]-mediated phenotypes were assayed by growing cultures to mid-log
phase in YPD or dropout media to select for a plasmid if necessary. All
cultures within a single experiment were normalized to the same density by
A600 before making fivefold serial dilutions. All phenotypes were assayed
multiple times from independent cultures with identical results.
Biochemical Analysis
Sup35p aggregates were analyzed by semidenaturing detergent agarose gel
electrophoresis (SDD-AGE) as previously described (Bagriantsev and Lieb-
man, 2004) with the modifications of Tank et al. (2007). Unless indicated
differently in the figure legend or text, samples were incubated for 7 min at
room temperature before being loaded on the gel.
To examine Sup35p and Ctr9p expression levels, protein lysates were
prepared as for SDD-AGE except denaturing loading buffer (50 mM Tris-HCl,
pH 6.8, 2% SDS, 0.1% bromophenol blue, 10% glycerol, and 100 mM dithio-
threitol) was added to cleared lysates, and samples were incubated at 95°C for
5 min. Equal amounts of protein, as determined by Bradford Assay, were
loaded on polyacrylamide gels for SDS-PAGE. The protein was subsequently
transferred to PVDF for Western blotting. Membranes were probed with
antibodies recognizing Sup35p (Patino et al., 1996; diluted 1:2000), Ctr9p
yN-18 (Santa Cruz Biotechnology, Santa Cruz, CA; diluted 1:400), or Pgk1p
(Molecular Probes, Eugene, OR; diluted 1:10,000) followed by horseradish
peroxidase-conjugated goat anti-rabbit IgG (Sigma-Aldrich, St. Louis, MO;
diluted 1:10,000), rabbit anti-goat IgG (Jackson ImmunoResearch Laborato-
ries, West Grove, PA; diluted 1:4000), or rabbit anti-mouse IgG (Sigma-
Aldrich; diluted 1:10,000), respectively. Immunoblots were developed using
enhanced chemiluminescence.
Fluorescence Microscopy
Yeast strains were transformed with the copper-inducible plasmid mCNMG
containing a fusion between sequences coding for the Sup35p prion domain
(NM) and green fluorescent protein (GFP; Patino et al., 1996). Expression of
the fusion protein was induced with a final concentration of 60 M copper
sulfate for 6 h before visualization. Visualization was on an Olympus IX70
fluorescence microscope (Melville, NY) equipped with an enhanced GFP filter
cube and a Photometrics Coolsnap HQ camera and QED in vivo software
(Tucson, AZ).
Read-through Assay
ß-Galactosidase reporter plasmids pUKC817, pUKC818, and pUKC819
(Stansfield et al., 1995a) were provided by M. Tuite (University of Kent,
Canterbury, United Kingdom). Transformants were grown to log-phase in
liquid culture, harvested by centrifugation, lysed with glass beads, and as-
sayed by the Galacto-Light Chemiluminescent Reporter Gene Assay System
(Applied Biosystems, Bedford, MA). Detection was on a Sirius Single Tube
Luminometer (Berthold Detection Systems, Pforzheim, Germany) with a de-
lay time of 2.0 s and read time of 5.0 s. For each strain, read-through was
calculated from three independent cultures as the average relative light units
per microgram of protein assayed as determined by Bradford Assay. Read-
through for the [psi] culture was set to a value of 1.0 and read-through for
each of the other strains was expressed as the fold-change from [psi]. This
method of normalization was used because our data suggest that each indi-
vidual transcript may be influenced differently by the loss of Ctr9.
Northern Blot
Total RNA was isolated as described (Schmitt et al., 1990). Briefly, total RNA
was extracted using three organic extractions: once in hot, acidic phenol-
chloroform and twice in cold, acidic phenol-chloroform. The RNA was pre-
cipitated overnight with 3 M sodium acetate, pH 5.2, and 100% ethanol at
20°C. The RNA pellet was washed once in 70% ethanol and resuspended in
diethylpyrocarbonate (DEPC)-treated water. Equal amounts (20 g) of RNA
was loaded onto a 0.8% denaturing formaldehyde agarose gel in 1 MOPS
buffer. RNA was transferred onto a nylon membrane (Amersham, Piscat-
away, NJ; Hybond-N) by capillary action overnight. The membrane was
stained with methylene blue to visualize the 18S and 25S rRNA. The RNA was
UV-cross-linked onto the membrane. The membrane was prehybridized in
Amersham Rapid-hyb Buffer at 55°C for 1 h. Radioactive probes for the
Northern analysis were prepared by random primed labeling of ADE1 PCR
product (Roche, Indianapolis, IN). The oligos used to amplify ADE1 product
were 5 ATGTCAATTACGAAGACT and 5 TTAGTGAGACCATTTA-
GACCC. Hybridization was performed at 55°C for 2 h. The membrane was
washed three times: once for 15 min at room temperature, followed by a 30
min wash at 60°C (1 SSPE, 0.1% SDS), and final wash for 45 min at 60°C
(0.5 SSPE, 0.25% SDS). The membrane was exposed to film for visualization
of bands.
3 RACE and Quantitative RT-PCR Analysis
Total RNA was isolated as described above. Total RNA, 5 g, was reverse-
transcribed using Superscript III (Invitrogen, Carlsbad, CA) and 50 M of an
oligo adaptor-dT19: 5 GTTTCCCAGTCAGATCTTTTTTTTTTTTTTTTTTT.
The RNA was reverse transcribed at 50°C for 1 h, and the reverse transcrip-
tase was inactivated at 70°C for 15 min. The cDNA was subsequently treated
with RNase H at 37°C for 20 min. The cDNA was diluted 20-fold into a 50-l
PCR reaction. The oligos used in the PCR amplification were 5 TACGGATC-
CTATGAAACATTGACAGGGTC and 5 GTTTCCCAGTCAGATCT. The 3
RACE reactions were resolved on a 1.5% agarose gel. Quantitative RT-PCR
(qRT-PCR) was performed using Sybr-Green (Bio-Rad, Richmond, CA) ac-
cording to the manufacturer’s instructions. The PCR products for LacZ and
ACT1 were generated using the following primer pairs: LacZ, 5 GTTGCT-
GATTCGAGGCGTTAAC and 5 GGCTTCATCCACCACATACAG and
ACT1, 5 CTACGTTTCCATCCAAGCCG and 5 CCACGTTCACTCAA-
GATCTTC.
Invasive Growth Assay
Invasive growth was assayed as described previously (Roberts and Fink,
1994).
RESULTS
Identification of Mutants with Weakened Nonsense
Suppression
Read-through of stop codons during translation (nonsense
suppression) to produce elongated polypeptide chains is
one mechanism that can give rise to phenotypic variability
(True and Lindquist, 2000; True et al., 2004; Wilson et al.,
2005). The [PSI] prion reduces the fidelity of translation
termination in a slightly metastable, yet heritable manner,
and has been shown to influence the phenotype of numer-
ous traits in yeast (True and Lindquist, 2000). Further, many
of these traits are complex in nature (True et al., 2004).
Although many of the phenotypes require nonsense sup-
pression, other gene products appear to interact and con-
tribute. With the goal of understanding how [PSI] interacts
with other cellular components to contribute to genetic vari-
ation and phenotypic diversity, we screened for factors that
weakened the nonsense suppression of a [PSI] yeast strain.
Nonsense suppression is commonly monitored using
auxotrophic alleles of biosynthetic pathway genes that con-
tain premature stop codons (Chernoff et al., 2002). For exam-
ple, the ade1-14 allele contains a premature stop codon in the
ADE1 gene that encodes a component of the adenine bio-
synthetic pathway. Because cells with the ade1-14 allele do
not make enough functional Ade1 protein, they require ad-
enine in the media to grow. Although they grow well on rich
medium, [psi] ade1-14 cells accumulate an intermediate in
the adenine biosynthetic pathway that causes the colonies to
be red in color. In [PSI] cells, however, translation pro-
ceeds through the stop codon to produce some full-length
Ade1 protein and thereby complete the adenine biosynthetic
pathway. Thus, [PSI] ade1-14 cells do not require adenine
in the media, and the colonies are white or pale pink in color.
We utilized the ade1-14 allele in the 74-D694 yeast strain to
screen for factors that weaken the nonsense suppression of a
strong [PSI] variant. Cells with weakened nonsense sup-
pression should make less Ade1 protein and produce darker
pink colonies than strong [PSI]. Wild-type pale pink
[PSI] ade1-14 cells were mutagenized with ethylmethane
sulfonate to 17% viability, and the resulting colonies were
screened visually for a darker pink color. Of 133,000 colonies
screened, 32 consistently produced darker pink colonies
than wild-type strong [PSI] after multiple restreaks.
ctr9 Weakens Nonsense Suppression
One mutant (SV16) will be described here. The SV16 mutant
strain produces medium pink colonies on rich media (YPD)
and grows slowly on media lacking adenine (SD-ade) com-
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pared with unmutagenized strong [PSI] cells (Figure 1A).
The [PSI] prion can be cured by transient growth on media
containing millimolar amounts of GdnHCl (Tuite et al.,
1981). Interestingly, SV16 cells were inviable in the presence
of 3 mM GdnHCl (Figure 1A). However, the SV16 mutant
was viable on lower concentrations of GdnHCl and was able
to be cured of the [PSI] prion (data not shown).
The SV16 mutant was backcrossed to a wild-type 74-D694
[psi] strain, and the resulting diploid was analyzed. The
diploid produced pale pink colonies on rich media and grew
well on SD-ade (Figure 1B), indicating that the SV16 muta-
tion was recessive and that the mutant still contained the
[PSI] prion. When the meiotic progeny were analyzed, two
haploids were pale pink and two were medium pink in each
tetrad. The 2:2 segregation pattern suggested that a single
mutation was contributing to the phenotype. Furthermore,
the recovery of strong [PSI] haploids in each tetrad indi-
cated that the mutation had to be present to obtain the
reduced nonsense suppression and that the mutation had
not permanently altered the structure to create a new prion
strain variant.
To identify the mutation in SV16, we complemented the
weak nonsense suppression phenotype with two yeast
genomic libraries. Complementation was assayed by robust
growth on media lacking adenine and by resistance to 3 mM
GdnHCl. Six plasmids were identified that complemented
both phenotypes and passed all secondary tests (data not
shown). The ends of each rescuing library plasmid were
sequenced. All six plasmids contained overlapping genomic
fragments. Only one gene, CTR9, was common to all six
plasmids. Ctr9p is a component of the Paf1 protein complex
(Paf1C) implicated in the transcription and transcriptional
processing of some mRNAs (Shi et al., 1996; Koch et al., 1999;
Krogan et al., 2002; Mueller and Jaehning, 2002; Pokholok et
al., 2002; Squazzo et al., 2002; Mueller et al., 2004; Rondon et
al., 2004; Penheiter et al., 2005). To test whether the increase
in nonsense suppression conferred by the library plasmids
to SV16 was specific to the SV16 mutant or due to a general
increase in nonsense suppression, we transformed a repre-
sentative library plasmid containing CTR9 into a wild-type
[psi] strain as well as strong and weak variants of [PSI].
The library plasmid did not significantly affect the color of
the wild-type [PSI] or [psi] strains on rich media or their
growth on media lacking adenine (Figure 2A).
Because CTR9 was the only gene in common to all six
library plasmids, we tested whether CTR9 was responsible
for the complementation of SV16. CTR9 was cloned and
tested for complementation of the reduced growth of SV16
on SD-ade and for rescue of other phenotypes associated
with SV16. During our analysis we found that the SV16
mutant grows slower than wild-type, is slightly temperature
sensitive at 37°C, and is hypersensitive to hygromycin B,
neomycin sulfate, and hydroxyurea (Figure 2B and data not
shown). The introduction of wild-type CTR9 on a plasmid
Figure 1. Mutant strain SV16 contains a reces-
sive, Mendelian mutation that weakens the non-
sense suppression of [PSI]. (A) Fivefold serial
dilutions of indicated yeast cultures at equal cell
density were spotted onto YPD, SD-ade, and YPD
containing 3 mM GdnHCl. s[PSI] and w[PSI] ,
strong and weak [PSI] strains, respectively. (B)
Spotting of [psi], SV16, and the wild-type [psi]
 SV16 diploid on YPD, SD-ade, and YPD con-
taining 3 mM GdnHCl (top). Two representative
tetrads from sporulation of the wild-type [psi] 
SV16 diploid are shown (bottom). Asterisks de-
note spores that inherited the mutant allele.
Figure 2. CTR9 complements SV16 phenotypes. (A) Strong (s) [PSI],
weak (w) [PSI], and [psi] strains were transformed with pRS315 empty
vector or the A3 library plasmid (LEU2 vector with a genomic region
containing CTR9). Liquid cultures were normalized to equal cell density
and fivefold serial dilutions were spotted onto YPD, SD-leu-ade, and YPD
 3 mM GdnHCl. (B) SV16 was transformed with pRS316kanMX4 empty
vector, pRS316kanMX4-CTR9, or pRS316kanMX4-SV16ctr9. Liquid cul-
tures of the resulting transformants were normalized and spotted as in A
onto YPD  200 mg/l G418 (to select for the plasmid), SD-ura-ade, YPD 
200 mg/l G418  3 mM GdnHCl, YPD  25 g/ml hygromycin B, and
YPD  20 mg/ml neomycin sulfate.
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permitted the rapid growth of SV16 on SD-ade compared
with the empty vector (Figure 2B). In addition, CTR9
complemented the slow-growth phenotype of SV16 on
rich media as well as the sensitivities to GdnHCl, hygro-
mycin B, and neomycin sulfate (Figure 2B). Moreover,
when we cloned the ctr9 allele out of the SV16 mutant into
the same vector and tested it for complementation, we
found that it failed to rescue any of the SV16 mutant
phenotypes (Figure 2B).
Because CTR9 rescued the weakened nonsense suppres-
sion phenotype of SV16, we hypothesized that a mutation in
CTR9 may be responsible for the weakened nonsense sup-
pression in the SV16 mutant. We sequenced CTR9 from
SV16 and the isogenic wild-type strain and found one dif-
ference that resulted in a change in amino acid (C227Y) in
the SV16 mutant compared with wild-type.
If the C227Y mutation in ctr9 was in fact causing the
recessive phenotypes of the SV16 mutant, then we predicted
that the complete deletion of the nonessential CTR9 gene
would also weaken nonsense suppression. The entire CTR9
open reading frame was deleted in strong [PSI], weak
[PSI], [psi], and SV16 strains and the resulting strains
were assessed phenotypically. Deletion of CTR9 did reduce
the [PSI]-mediated nonsense suppression of the ade1-14
allele (Figure 3). The null mutant produced darker pink
colonies on YPD in the strong [PSI] strain. In addition,
ctr9 in a strong [PSI] strain grew significantly slower on
SD-ade than the wild-type strong [PSI] strain. When ctr9
was deleted in a weak [PSI] strain, the colonies became red
in color and did not grow on media lacking adenine. Be-
cause these colonies appeared phenotypically like [psi], we
wanted to determine if [PSI] was still present. Deletion of
CTR9 could cure the weak [PSI] prion. Alternatively, the
[PSI] prion could still be present but phenotypically
masked by more faithful translation termination at the pre-
mature ade1-14 stop codon in the CTR9 deletion. To geneti-
cally test for the presence of [PSI], we crossed ctr9 made
in the weak [PSI] strain to a [psi] strain and examined the
color of the resulting diploids on YPD. If [PSI] was present
but masked in the ctr9 strains, then the diploid would
appear pink because of the rescued nonsense suppression by
one wild-type copy of CTR9 in the diploid. However, if
[PSI] had been cured by the deletion of CTR9, then the
diploid would be red. The diploid was pink in color, indi-
cating deletion of CTR9 did not cure weak [PSI] (data not
shown). We also tested for the presence of aggregated
Sup35p in [PSI] ctr9. Sup35 protein aggregates were still
detected by SDD-AGE (data not shown). Collectively, this
data suggests that the [PSI] prion was still present and that
deletion of CTR9 reduced the nonsense suppression pheno-
type of [PSI]. In addition, ctr9 in strong [PSI], weak
[PSI], and [psi] strains were all temperature sensitive at
37°C and produced similar sensitivities to GdnHCl, hygro-
mycin B, neomycin sulfate, and hydroxyurea as the SV16
point mutant (Figure 3 and data not shown).
We also knocked out ctr9 from the SV16 mutant strain.
Interestingly, we noted that the complete deletion of ctr9 in
the SV16 strain was phenotypically similar to the SV16 point
mutant (Figure 3), suggesting that the Ctr9-C227Y protein
could be produced at a lower level, unstable, or severely
impaired functionally. To test if the Ctr9-C227Y protein was
present at a steady-state level similar to wild-type, lysates
were prepared from wild-type and ctr9-C227Y [PSI]
strains and equal protein quantities were analyzed by SDS-
PAGE and immunoblotting with antibodies to Ctr9p. The
Ctr9-C227Y protein was barely detectable compared with
wild-type Ctr9p (data not shown), suggesting less mutant
protein is made or that it is very unstable.
Loss of Select Paf1C Members Also Reduces Nonsense
Suppression
Because Ctr9p is part of a protein complex that contains
Paf1p, Cdc73p, Leo1p, and Rtf1p (Koch et al., 1999; Krogan et
al., 2002; Mueller and Jaehning, 2002; Squazzo et al., 2002),
we tested whether other members of the complex also af-
fected [PSI]-mediated nonsense suppression. Deletions of
CTR9 and PAF1 have been reported to have many pheno-
types in common, whereas deletion of other members of
Paf1C often produces fewer and weaker phenotypes (Betz et
al., 2002; Mueller and Jaehning, 2002). Because CTR9 influ-
ences nonsense suppression, we predicted that the deletion
of other Paf1C members would also affect the [PSI] phe-
notype. We individually deleted the genes encoding mem-
bers of Paf1C in strong [PSI], weak [PSI], [psi], and
Figure 3. ctr9 reduces nonsense suppression of strong and weak [PSI] and exhibits phenotypes similar to SV16. CTR9 was deleted in
strong (s) [PSI], weak (w) [PSI], [psi], and SV16 strains. Liquid cultures were normalized to equal cell density, and fivefold serial
dilutions were spotted onto the indicated media. Drug concentrations in the media are the same as those listed in the legend of Figure 2.
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SV16 strains. The deletion of PAF1 weakened nonsense sup-
pression in both strong and weak [PSI] strains and ren-
dered the cells sensitive to GdnHCl (Figure 4A).
The individual deletion of RTF1 also weakened nonsense
suppression in both strong and weak [PSI] strains (Sup-
plemental Figure S1). However, rtf1 strains were only
mildly sensitive to GdnHCl (data not shown). Interestingly,
the deletion of CDC73 resulted in an intermediate pheno-
type. Weakened nonsense suppression of ade1-14 by cdc73
was readily detected in a weak [PSI] strain but not in a
strong [PSI] strain (Supplemental Figure S1). It is possible
that cdc73 does weaken nonsense suppression in a strong
[PSI] strain but that a more sensitive assay is required to
detect it. Deletion of LEO1 had no detectable effect on non-
sense suppression of ade1-14 in either strong or weak [PSI]
strains by this assay (Supplemental Figure S1). Moreover,
cdc73 and leo1 strains were not sensitive to GdnHCl (data
not shown).
Deletion of RTF1 Suppresses Some of the SV16 Phenotypes
Loss of Leo1p or Rtf1p has been reported to suppress many
of the phenotypes of ctr9 and paf1 mutants (Mueller and
Jaehning, 2002). To test whether the loss of other compo-
nents of Paf1C can suppress the ctr9-C227Y mutant, we
assayed deletions of PAF1, CDC73, LEO1, and RTF1 in the
SV16 mutant strain for rescue of the ctr9-C227Y phenotypes.
The deletions of PAF1, CDC73, and LEO1 had no significant
effect on the nonsense suppression of the ade1-14 allele in the
[PSI] SV16 strain (Figures 4A and Supplemental Figure
S1). Interestingly, rtf1 suppressed some of the phenotypes
associated with ctr9-C227Y in the SV16 mutant strain. Loss
of Rtf1p suppressed the sensitivity of SV16 to 3 mM GdnHCl
and 0.15 M hydroxyurea (Figure 4B and data not shown).
However, it did not alter the level of nonsense suppression
of ade1-14 (Figures 4B and Supplemental Figure S1).
To determine whether another member of Paf1C can func-
tionally replace Ctr9p in translation termination, we assayed
whether the overexpression of PAF1, CDC73, LEO1, or RTF1
could suppress the phenotypes of the SV16 mutant. None of
the other Paf1C components expressed from a 2-m plasmid
restored the nonsense suppression of ade1-14 or the GdnHCl
resistance in the [PSI] SV16 mutant strain (data not
shown).
Loss of CTR9 Alters Sup35p Aggregates
In [PSI] cells, Sup35p is aggregated in a heritable, self-
propagating conformation (Patino et al., 1996; Paushkin et al.,
1996). One way mutants of CTR9 could affect nonsense
suppression in [PSI] cells is by altering the expression or
aggregation of Sup35p. To determine if the level of Sup35
protein was altered by ctr9-C227Y or ctr9, Sup35p levels in
the SV16 and ctr9 strains were compared with a wild-type
[PSI] strain by Western blot. No change in the steady-state
Sup35p level was detected between the wild-type and mu-
tant strains (Figure 5A), indicating that the weakened non-
sense suppression in the CTR9 mutants cannot be explained
simply by a difference in the amount of total Sup35p.
Another mechanism by which ctr9 could weaken non-
sense suppression in [PSI] cells is by altering the aggrega-
tion of the Sup35p. Mutants of CTR9 could alter the confor-
mation of the aggregates, resulting in a change in the [PSI]
strain variant being propagated by the cells. In addition, the
stability of the aggregates could be altered such that a
smaller percentage of the Sup35p is aggregated, thereby
generating a larger pool of soluble Sup35p for translation
termination activity. We examined these possibilities by sev-
eral complementary methods. First, we tested whether the
Sup35p was still aggregated in the SV16 mutant by ectopi-
cally expressing the prion forming domain of Sup35 (NM)
fused to GFP and visualizing the cells by direct fluorescence
microscopy. NM-GFP gets incorporated into the preexisting
Sup35p aggregates in [PSI] cells, thereby acting as an
indicator of the [PSI] state (Patino et al., 1996; Lindquist et al.,
2001). One to three large, bright foci were typically observed
in cells when NM-GFP was expressed in strong and weak
[PSI] strains (Figure 5B). In contrast, no foci were present
in [psi] cells, and NM-GFP was diffuse in the cytoplasm.
When NM-GFP was expressed in the SV16 mutant, foci were
observed, indicating that Sup35p was still aggregated (Fig-
ure 5B). In some cells, the amount of diffuse NM-GFP in the
cytoplasm appeared to be increased in the SV16 mutant
strain as compared with the wild-type strong and weak
[PSI] strains. However, this was not uniform among all
cells examined (data not shown).
Second, we determined if there was a gross change in the
size or conformation of the Sup35p aggregates by SDD-AGE.
The difference in size of the aggregates between prion strain
variants can be detected as a change in electrophoretic mo-
bility by SDD-AGE (Kryndushkin et al., 2003). As seen pre-
viously (Kryndushkin et al., 2003), Sup35p from a strong
[PSI] strain migrated slightly farther into the gel than
Sup35p from a weak [PSI] strain (Figure 5C). In the SV16
and ctr9 [PSI] strains, the smear of Sup35p aggregates
migrated even farther into the gel than strong [PSI], and
Figure 4. Some components of Paf1C affect nonsense suppression
of [PSI]. (A) Deletion of PAF1 weakens [PSI]-mediated nonsense
suppression. Deletions of PAF1 were made in the following strains:
strong (s) [PSI], weak (w) [PSI], [psi], and SV16. Each deletion
mutant and parental wild-type control strain was spotted as de-
scribed in the legend of Figure 3. (B) Deletion of RTF1 suppresses
the GdnHCl sensitivity of SV16 but not the reduction in nonsense
suppression of ade1-14. A wild-type (wt) strong [PSI] strain, SV16,
SV16 rtf1, and strong [PSI] rtf1 strain were spotted as described
in the legend of Figure 3.
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the smear covers a slightly broader range (Figure 5C). In
addition, a small amount of monomeric Sup35p was some-
times detected in the SV16 and ctr9 mutants but not in
wild-type [PSI] (data not shown). To further investigate a
possible structural change in the Sup35p aggregates in the
mutants, we examined their thermal stability. Protein lysates
from strong [PSI], weak [PSI], SV16, and ctr9 were
heated at various temperatures before SDD-AGE (Figure
5D). At 65°C, the Sup35p aggregates appeared similar to
those of the standard assay temperature of 25°C, but some
change in size or stability was beginning to be apparent for
strong [PSI], SV16, and ctr9 (compare 65°C in Figure 5D
with standard assay in Figure 5C). At 75°C, aggregates from
strong [PSI], but not weak [PSI], were broken down to
monomer. By 85°C, aggregates from weak [PSI] also began
to break down to show some monomeric protein. In the
SV16 and ctr9 mutant strains, the Sup35p aggregates broke
down to monomer at 75°C, similar to the strong [PSI]
strain. Taken together with our genetic data, this suggests
that although there may be a small effect on the size of the
Sup35p aggregates in the population within the SV16 and
ctr9 mutants, the heritable structure of the aggregates is not
grossly changed from those of the original strong [PSI]
parental strain.
ctr9 Alters Both the Aggregation of Sup35p and
Nonsense Suppression
Finally, we used genetic analyses to distinguish the effects of
CTR9 on the Sup35p aggregates in [PSI] cells from those
on translation termination and nonsense suppression. In
[psi] cells, mutations in the SUP35 C-terminal domain that
reduce function create a nonsense suppression phenotype
that mimics that of [PSI] cells (Wickner et al., 1995). Fur-
thermore, these Mendelian mutations cause inviability in
combination with [PSI] due to high levels of nonsense
suppression (Cox, 1977; Liebman and All-Robyn, 1984; Zhou
et al., 1999). We crossed one of these mutants, [psi] 74-D694
sup35-Y351C, to SV16, sporulated the diploid, and analyzed
the tetrads. Only two haploids were recovered from each
tetrad (data not shown), further supporting the cell biolog-
ical and biochemical results that the SV16 mutant still con-
tains the [PSI] prion. When we cured the diploid cells of
[PSI] by passaging them on media containing GdnHCl
before sporulation, all four meiotic progeny were viable.
Using these [psi] progeny, we then asked whether the
ctr9-C227Y mutant altered the nonsense suppression of a
sup35 genetic mutant. As shown by a representative tetrad in
Figure 6, the ctr9-C227Y sup35-Y351C double mutant exhib-
ited less nonsense suppression of the ade1-14 allele than the
sup35-Y351C mutant alone, suggesting that one way the ctr9
mutant is promoting more efficient termination is by genet-
ically modifying nonsense suppression. However, the effect
of ctr9-C227Y on [PSI] appeared to be stronger than on
sup35-Y351C, because the difference in color between [PSI]
ctr9-C227Y and the parental [PSI] strain is slightly greater
than it is between the ctr9-C227Y sup35-Y351C and sup35-
Figure 5. Sup35p aggregates in SV16 and ctr9 are similar to those
of strong [PSI]. (A) Mutations in CTR9 do not alter the steady-state
expression level of Sup35p. Equal quantities of protein were loaded
on a SDS-polyacrylamide gel, transferred to PVDF, and immuno-
blotted with antibodies recognizing Sup35p or Pgk1p. Pgk1p was
used as a control for equal loading. (B) NM-GFP aggregates in the
SV16 strain. NM-GFP was expressed in the indicated strains and
visualized by direct fluorescence microscopy after a 6-h induction
with 60 M copper sulfate. (C) Sup35p aggregates in SV16 and ctr9
strains migrate as a broader smear compared with those of strong
[PSI]. Equal amounts of protein were analyzed by SDD-AGE and
immunoblotting with antibodies recognizing Sup35p. The positions
of monomeric and aggregated Sup35p are indicated to the left of the
blot. (D) Sup35p aggregates in SV16 and ctr9 strains exhibit ther-
mal stability similar to those from a wild-type strong [PSI] strain.
SDD-AGE was performed as in C except the lysates were heated at
65, 75, or 85°C before loading on the gel. (A–D) s[PSI] and
w[PSI], strong and weak [PSI] strains, respectively.
Figure 6. ctr9-C227Y reduces nonsense suppression of ade1-14 in
the absence of Sup35p aggregates. SV16 [PSI] was crossed to
[psi] sup35-Y351C, and the resulting diploid was cured of [PSI]
by growth on media containing 3 mM GdnHCl before sporulation.
Fivefold serial dilutions of yeast cultures at equal cell density were
spotted on YPD and SD-ade. The top four rows show control strong
(s) [PSI] and [psi] strains and the [PSI] SV16 ([PSI] ctr9*) and
[psi] sup35-Y351C ([psi] sup35*) parental strains used to generate
the diploid. The bottom four rows show a representative tetrad with
genotype indicated on the left. Presence of the ctr9-C227Y and
sup35-Y351C alleles is designated with an asterisk adjacent to the
gene name. Wild-type alleles are designated in capital letters. All
progeny are [psi].
Paf1C Is a Genetic Modifier of [PSI]
Vol. 20, April 15, 2009 2235
Y351C strains (Figure 6, YPD). This is also consistent with
our result that ctr9 has some effect on the size of the Sup35p
aggregates in [PSI] (Figure 5C). This suggests that the loss
of Ctr9p may affect [PSI]-mediated phenotypes in multiple
ways (see below). We next tested whether the effects of Ctr9
on nonsense suppression were specific to Sup35. The non-
sense suppression phenotype resulting from mutations in
sup45 is also reduced in ctr9 strains (Supplemental Figure
S2). The extent to which the loss of Ctr9 alters nonsense
suppression of sup45 mutants was not as striking as the
effect on [PSI]-mediated nonsense suppression.
Ctr9 Affects Transcript Processing and Translatability of
mRNA
The [PSI] prion causes suppression of all three stop codons
in yeast (Tuite et al., 1983; Firoozan et al., 1991). We have
shown that ctr9 weakens nonsense suppression of the
ade1-14 allele, which contains a premature UGA stop codon.
To investigate whether the effect of ctr9 on nonsense sup-
pression is specific to UGA and the ade1-14 allele, we ex-
pressed reporter constructs with each one of the stop codons
fused in front of lacZ (Stansfield et al., 1995a). If the stop
codon is read through in these reporters, then -galactosi-
dase is produced. Each reporter was expressed in wild-type
[PSI], [psi], and ctr9 [PSI] strains. As expected, the
strong [PSI] strain exhibited a higher level of read-through
of each stop codon than the isogenic [psi] strain (Figure
7A). Furthermore, the weak [PSI] strain produced a level
of read-through that was intermediate to the strong [PSI]
and [psi] strains. Deletion of CTR9 in strong [PSI] caused
a reduction in [PSI]-mediated nonsense suppression of all
three stop codons (Figure 7A), further supporting the idea
that ctr9 weakens nonsense suppression in general.
To investigate whether this reduction in read-through by
ctr9 was specific to the prion, we introduced the same
reporters into a [psi] sup35-Y351C ctr9 double mutant
strain along with each single mutant and the wild-type
control. The effect on read-through was not entirely specific
to the [PSI] prion for two reasons. First, the [psi] ctr9
mutant alone had significantly lower read-through than the
[psi] wild-type strain (Figure 7B; unpaired t test, p  0.0003
for all stop codons), indicating that the loss of Ctr9p reduces
basal read-through of UAA, UAG, and UGA stop codons.
Second, the sup35-Y351C ctr9 double mutant also had sig-
nificantly lower read-through of all three stop codons than
the sup35-Y351C mutant alone (Figure 7B; unpaired t test,
p  0.0024 for all stop codons). Interestingly, ctr9 had a
greater effect on [PSI]-mediated read-through than on
sup35-Y351C-mediated read-through for each of the stop
codons (compare fold change in Figure 7, A and B). The
effect is more striking on UAG and UGA than on UAA. This
difference, along with the slight effect of ctr9 on the size of
the Sup35p aggregates (Figure 5C), supports the idea that
ctr9 affects [PSI]-mediated nonsense suppression in mul-
tiple ways. Collectively, these results indicate that nonsense
suppression of all three stop codons is reduced in the ab-
sence of Ctr9p.
Interestingly, we also noted a twofold reduction in the
level of specific activity of -galactosidase with the deletion
of ctr9 using the nonstop control lacZ constructs. This sug-
gests that Ctr9 and the Paf1 complex effects transcript sta-
bility or translatability of the mRNA. Indeed, qRT-PCR con-
firmed a reduction in the steady-state level of nonstop lacZ
mRNA (eightfold), and the reduction was verified by North-
ern blot (data not shown).
Next, we wanted to test if the level of ade1-14 transcript
was reduced, hence accounting for the decreased amount of
Ade1 product and change in phenotype in ctr9. Curiously,
we did not find a change in the steady-state levels of ade1-14
transcript by Northern blot analysis (Figure 8A, top). Load-
ing of RNA was assessed by methylene blue staining of the
18S and 25S rRNA (Figure 8A, bottom). Because there was
no change in the levels of ade1-14 transcript, another possi-
bility that could account for the reduced amount of Ade1p in
ctr9 would be a change in the translatability of the ade1-14
mRNA. Supporting this hypothesis, a recent genome-wide
analysis revealed that ADE1 transcript was predicted to
have two or more poly(A) addition sites (Nagalakshmi et al.,
2008). Because the Paf1C has been shown to play a role in
posttranscriptional 3end processing (Penheiter et al., 2005;
Nordick et al., 2008), we wanted to test if the loss of CTR9
could affect the 3 end processing of the ade1-14 transcript
and consequently affect its translatability. Using 3 rapid
amplification of cDNA ends (RACE) analysis, we found that
the shorter product of the ade1-14 3 end was the predomi-
nant isoform in ctr9 mutant as compared with a longer
product in the wild-type strain (Figure 8B).
Phenotypic Effects of ctr9 Are Not Limited to ade1-14
Isogenic [PSI] and [psi] yeast strains differ in numerous
different growth phenotypes, many of which can be attrib-
Figure 7. Deletion of CTR9 reduces nonsense suppression of all
three stop codons. Read-through of reporter constructs containing
the indicated stop codon was assayed and expressed as the fold
change of the [psi] strain. Each bar in the graphs represents the
mean and SD of three independent cultures assayed on the same
day. Whereas the absolute fold change varied between days, the
overall trend remained the same. (A) ctr9 reduces nonsense sup-
pression by [PSI] at each of the stop codons. s[PSI] and w[PSI],
strong and weak [PSI] strains, respectively. (B) ctr9 also reduces
nonsense suppression by sup35-Y351C (designated sup35*). All
strains are [psi]. WT, wild-type.
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uted to [PSI]-mediated nonsense suppression (True and
Lindquist, 2000; True et al., 2004). We wanted to determine if
the loss of Ctr9p affected any of these [PSI]-dependent
traits. Few strong [PSI]-dependent phenotypes were pre-
viously reported in the 74-D694 strain background (True
and Lindquist, 2000). However, many [PSI]-dependent
phenotypes were identified in the 5V-H19 and 10B-H49
yeast strain backgrounds (True and Lindquist, 2000). There-
fore, we made deletions of CTR9 in [PSI] isolates of 5V-
H19 and 10B-H49, cured the prion to obtain isogenic [psi]
ctr9 strains, and examined the strain pairs for the effect of
ctr9 on some of the previously reported [PSI]-dependent
traits (True and Lindquist, 2000). Because ctr9 alone is
sensitive to many different growth conditions and com-
pounds (Betz et al., 2002 and this study), we were limited in
the number and range of phenotypes we could test.
Both 5V-H19 and 10B-H49 contain a premature UAA stop
codon in ADE2 (the ade2-1 allele) that is suppressible by
[PSI]. Similar to our results with ade1-14 in 74-D694, ctr9
weakened [PSI]-mediated nonsense suppression of ade2-1
in both 5V-H19 and 10B-H49 (data not shown). 10B-H49 also
contains a [PSI]-suppressible allele of LYS1 (lys1-1), a com-
ponent of the lysine biosynthetic pathway. 10B-H49 [psi]
cells grow poorly on media lacking lysine because they are
unable to make enough full-length Lys1p. However, 10B-
H49 [PSI] cells make more Lys1p and can grow in the
absence of lysine. When we deleted CTR9 in the 10B-H49
[PSI] strain, the colonies grew slower than the wild-type
10B-H49 [PSI] strain on media lacking lysine (Figure 9A),
suggesting ctr9 weakened the nonsense suppression of
lys1-1. Another [PSI]-dependent phenotype in 10B-H49 is
resistance to cycloheximide. However, the gene target(s) of
[PSI] that contribute to this phenotype are not yet known.
10B-H49 [PSI] cells grow better than isogenic [psi] cells in
the presence of 0.2 g/ml cycloheximide (True and
Lindquist, 2000 and Figure 8A). Surprisingly, the [psi]
ctr9 strain was more resistant to cycloheximide than the
wild-type [psi] strain (Figure 9A).
Invasive growth and flocculation are two related [PSI]-
dependent phenotypes in 5V-H19 (True and Lindquist, 2000
and Figure 8B). [PSI] cells invade the agar during growth
on solid media and flocculate in liquid media, whereas
[psi] cells do not invade the agar and do not flocculate.
When we deleted CTR9 from 5V-H19 [PSI] cells, the cells
invaded the agar much less than the wild-type [PSI] strain
on solid media and no longer flocculated in liquid media
(Figure 9B and data not shown). Another [PSI]-dependent
trait in 5V-H19 that may be related to the flocculation and
invasive growth phenotypes is a change in colony morphol-
ogy. [PSI] cells produce large colonies with a puckered
and dimpled surface when grown on media containing 3%
potassium acetate as the sole carbon source (True and
Lindquist, 2000). In contrast, [psi] cells produce smaller
colonies with a smooth, rounded surface. The genes influ-
enced by [PSI] that are associated with this phenotype are
unknown. However, the phenotype can be at least partially
Figure 8. ctr9 alters the 3 processing of the ade1-14 transcript. (A)
Northern analysis of ade1-14 transcript levels are shown (top). Equal
amounts of total RNA was loaded on the gel, and this was visual-
ized by methylene blue staining of 18S and 25S rRNA (bottom). One
representative blot is shown. (B) 3 RACE analysis of total RNA
isolated from wild-type (WT) and ctr9 strains. The ade1-14 tran-
script has multiple isoforms in the WT and ctr9 strain. Arrow
indicates the predominant isoform that accumulates in the ctr9
strain. The molecular-weight marker in base pairs is indicated on
the left side of the gel.
Figure 9. ctr9 modifies [PSI]-dependent
phenotypes. (A) CTR9 was deleted in [PSI]
and [psi] derivatives of 10B-H49 and assayed
for nonsense suppression of the lys1-1 allele on
SD-lys  glycerol and for the alteration of
[PSI]-dependent cycloheximide resistance
(YPD  0.2 g/ml cycloheximide). (B) Wild-
type (WT) [psi], wild-type [PSI], and
[PSI] ctr9 derivatives of 5V-H19 were
grown on YPD (pre-wash) and assayed for
invasive growth by washing the plate with
distilled water (post-wash). (C) Colony mor-
phology of the same strains as B grown on
media containing potassium acetate as the sole
carbon source. The puckered colony morphol-
ogy was reduced in strong [PSI] ctr9 but
not completely lost.
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attributed to nonsense suppression (H. L. True, unpublished
data). Loss of Ctr9p in the [PSI] strain caused the cells to
revert to a more [psi]-like appearance (Figure 9C). Collec-
tively, these results show that ctr9 modifies multiple
[PSI]-dependent phenotypes.
DISCUSSION
We identified Ctr9p, a component of Paf1C, in a screen for
factors that weaken [PSI]-mediated nonsense suppression.
Furthermore, we show that other members of the complex
also affect [PSI]-mediated nonsense suppression. In addi-
tion to Ctr9p and Paf1p, the complex is composed of
Cdc73p, Leo1p, and Rtf1p (Koch et al., 1999; Krogan et al.,
2002; Mueller and Jaehning, 2002; Squazzo et al., 2002).
Paf1C is conserved from yeast to humans (Rozenblatt-Rosen
et al., 2005; Zhu et al., 2005). However, the complex in
humans does not appear to contain Rtf1p even though a
homolog exists. We show that the loss of Paf1C weakens
nonsense suppression and is a genetic modifier of [PSI]-
dependent phenotypes. How might Paf1C affect nonsense
suppression? One possibility is that Paf1C is affecting tran-
script levels via initiation or elongation by RNA polymerase
II. Paf1C is associated with RNA polymerase II from the
promoters to the polyadenylation (polyA) sites of actively
transcribed genes and is involved in the transcription and
posttranscriptional processing of some mRNAs (Shi et al.,
1996; Wade et al., 1996; Krogan et al., 2002; Pokholok et al.,
2002; Squazzo et al., 2002; Mueller et al., 2004; Rondon
et al., 2004; Penheiter et al., 2005; Nordick et al., 2008). Paf1C
has been reported to influence the efficiency of transcription
initiation and elongation (Pokholok et al., 2002; Squazzo et
al., 2002; Rondon et al., 2004). However, it is unclear whether
Paf1C directly affects these processes (Mueller et al., 2004;
Penheiter et al., 2005). Paf1C is required for methylation of
histone H3 (Krogan et al., 2003a,b; Ng et al., 2003), monou-
biquitylation of histone H2B (Xiao et al., 2005), 3 end for-
mation of snoRNAs (Sheldon et al., 2005), and 3 end forma-
tion of mRNAs in determining polyA site usage and polyA
tail length (Penheiter et al., 2005). Recent work suggests that
the influence of Paf1C on some histone modifications is
likely to be an indirect consequence of reduced methyltrans-
ferase recruitment to RNA polymerase II in Paf1C mutants
(Nordick et al., 2008).
The function of Paf1C in 3 end formation of mRNAs is
just beginning to be unraveled. Loss of Paf1C components
leads to altered transcripts due to the change in usage of
more distal polyA sites (Penheiter et al., 2005; Nordick et al.,
2008). This effect on 3 end formation has been characterized
for specific transcripts (Penheiter et al., 2005; Nordick et al.,
2008), but it is likely that more targets exist (Mozdy et al.,
2008). Links between Paf1C and other factors that affect
posttranscriptional 3 end formation have recently been
identified. Paf1C is required for the recruitment of cleavage
and polyadenylation factors Cft1p and Pcf11p to RNA poly-
merase II (Mueller et al., 2004; Nordick et al., 2008). It was
also shown that Paf1C directly binds Cft1p (Nordick et al.,
2008).
One explanation for the influence of Paf1C on the pheno-
typic effects of [PSI]-mediated nonsense suppression is via
its effects on posttranscriptional 3 end formation. Loss of
Paf1C produces transcripts that have an altered 3 end (Pen-
heiter et al., 2005; Nordick et al., 2008). The 3-extended
MAK21 transcripts in paf1 cells were targeted for degrada-
tion by the nonsense-mediated decay pathway, causing a
reduction in the steady-state level of MAK21 transcript (Pen-
heiter et al., 2005). This is likely to be true of additional
targets of Paf1C; transcripts altered in 3 end position and
polyadenylation can be targeted for rapid degradation by
the nonsense mediated decay pathway (Muhlrad and
Parker, 1999). If the transcripts subjected to [PSI]-mediated
read-through are also targets of Paf1C-mediated processing,
then we would expect that the loss of Paf1C components
could lead to 3-extended transcripts that are unstable. A
smaller pool of transcript should result in less overall sub-
strate for translation and translational read-through in
[PSI] cells that would thereby alter [PSI]-mediated phe-
notypes. However, a change in the 3 end processing may
not alter transcript stability but may change translatability of
the message. Indeed, the 3 untranslated region has been
shown to control polyadenylation of individual transcripts
and translational efficiency (Beilharz and Preiss, 2007). A
recent genome-wide study mapping transcribed regions in
S. cerevisiae identified 540 genes that utilize more than one
polyA site (Nagalakshmi et al., 2008). Interestingly, two sites
of polyA tail addition were identified for ADE1. Our results
demonstrate that individual deletions of CTR9, PAF1, RTF1,
and CDC73 weaken [PSI]-mediated nonsense suppression
of the ade1-14 allele. This may be a consequence of a change
in the utilization of the two polyA tail sites in ADE1. In
support of this, we detected a significant and reproducible
change in the ratio of the most abundant species of ade1-14
transcript in ctr9 compared with the wild-type strain by
3RACE. Interestingly, this change did not correspond to a
reduced steady-state level of ade1-14 mRNA in cells deleted
for ctr9. This suggests that there may be multiple ways by
which the Paf1 complex influences mRNA translatability.
We identified four other [PSI]-dependent phenotypes
(cycloheximide resistance, flocculation, invasive growth,
and colony morphology) that ctr9 modifies. Because the
loss of Ctr9p results in many drug sensitivities (Betz et al.,
2002 and this study), we speculate that more slight alter-
ations in the regulation of Paf1C might affect many other
[PSI]-dependent phenotypes. The genes involved in many
[PSI]-mediated phenotypes have not yet been identified.
The cycloheximide-resistance phenotype is particularly in-
teresting because [PSI] grows better than [psi], yet ctr9
causes the [psi] cells to become more resistant. This sug-
gests that producing less of a specific transcript increases
resistance to cycloheximide. If the ribosome reads through
the normal stop codon in [PSI] cells and reaches the 3 end
of the transcript without encountering another stop codon,
this would trigger nonstop decay. In [psi] cells, the tran-
script would be stable and translated, resulting in cyclohex-
imide sensitivity. Loss of CTR9 in [psi] cells could provide
a different mechanism to destabilize the transcript and make
cells more resistant to cycloheximide. Precedence exists for
changes in nonstop decay modifying [PSI]-dependent
phenotypes (Wilson et al., 2005). Moreover, Paf1C itself may
affect nonstop decay. The human PAF1C coimmunoprecipi-
tates with the human SKI complex that mediates nonstop
decay (Zhu et al., 2005). Furthermore, human PAF1C is
required for the recruitment of the SKI complex to transcrip-
tionally active genes (Zhu et al., 2005). Thus, different mech-
anisms to alter transcript stability could result in similar
phenotypic consequences.
The strain 5V-H19 shows a [PSI]-dependent increase in
flocculation and invasive growth. Flocculation and invasive
growth in yeast are regulated by the transcription factor
FLO8 (Kobayashi et al., 1996, 1999; Liu et al., 1996). FLO8 is
inactivated in many laboratory strains by a premature stop
codon (Liu et al., 1996). However, FLO8 is not mutated in the
5V-H19 strain background (H. L. True, unpublished data)
and is, therefore, not a likely target of read-through in 5V-
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H19 to produce the [PSI]-dependent flocculation and in-
vasive growth phenotypes. Loss of Paf1C reduces the effect
of [PSI] on flocculation and invasive growth. Interestingly,
Paf1C affects the modification of histones at FLO8. Trimethy-
lation of lysine 36 on histone 3 at FLO8 is reduced in paf1
and ctr9 mutants and acetylation of histones 3 and 4 on the
3 end of FLO8 is increased in paf1 and ctr9 mutants (Chu
et al., 2007). Although the genes involved in the [PSI]-
mediated changes in flocculation and invasive growth are
unknown, it is plausible to speculate that [PSI] and ctr9
affect different genes in the flocculation and invasive growth
pathways. However, for other phenotypes, both [PSI] and
Paf1C may affect the translation of the same transcript.
Transcriptional read-through of proximal polyA sites pre-
sumably occurs at a low rate. However, the use of alterna-
tive transcription termination sites may have biological
functions, including the regulation of viral gene expression
(Bousse et al., 2002; Poenisch et al., 2008). We describe an-
other scenario, one in which changes in posttranscriptional
processing modifies several [PSI]-dependent phenotypes
in yeast. The effect of Paf1C and 3 end formation on trans-
lational nonsense suppression adds to the growing list of
posttranscriptional processes that genetically modify
[PSI]-dependent traits. These links between transcriptional
and translational control highlight the potential continuum
for phenotypic diversity. If [PSI]-mediated read-through
provides an advantage to the organism whereby a pheno-
type can be altered in response to environmental changes,
the ability to fine-tune the traits during transitions may
enhance the organism’s ability to adapt and survive. We
have previously shown that it is possible to fix traits and
become [PSI]-independent (True et al., 2004). However, for
an organism that must thrive in a fluctuating environment,
fixation may not always be beneficial. Given that [PSI]-
mediated phenotypes are largely multifactorial, we postu-
late that there may be other global mechanisms for modu-
lating the spectrum of phenotypes. One such mechanism
may involve posttranscriptional processing through Paf1C.
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